Relapses are common, but difficult to predict and prevent.
ACR Issues Guidelines, Recommendations for Lupus Nephritis, RA
Detailed screening and treatment recommendations based on current evidence, extensive literature review.
Case Study: 66-Year-Old Man with Visual Loss, Headache, Hematuria, Chronic Sinusitis
A 66-year-old man presented to the hospital with left-sided visual loss, headache, hematuria, and symptoms of a chronic sinusitis.
Treatment Patterns and Trends for Spondylarthropathies
Methotrexate is a commonly used disease-modifying antirheumatic drug (DMARD) for treating patients with psoriatic arthritis (PsA). However, is it truly as effective as many think it is? That’s the question raised during the session “Spondylarthropathies: Recent Insights,” which took place at the 2011 ACR/ARHP Annual Scientific Meeting in November.
Quality Measurement Improves Rheumatology Outcomes
Innovations in health information technology can have significant impact
Making of the Guidelines
Panel considered new drugs and tools in the 2010 update
Glucocorticoids a Fracture Risk at Any Dose
Updated recommendations advocate doing more to determine fracture risk and the need for preventive therapy
The Evolution of Glucocorticoids
Hench lecturer highlights complexities of these steroid hormones’ signaling mechanisms
Best Lupus Treatment Still Up for Debate
Panel looks at decision making for treatment of three high-risk patients
Know Your Unknown Unknowns
Making life-or-death decisions based on unknown information is the challenge of medicine.
- « Previous Page
- 1
- …
- 3
- 4
- 5